Bond Screener
QuidelOrtho
LEI 549300X2FQ6S98OQLQ46
Organization name
QuidelOrtho Corporation (formerly Quidel Corporation)
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
-
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
QuidelOrtho Corporation (formerly Quidel Corporation) is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions primarily include applications in infectious diseases, women's health and gastrointestinal diseases.
|
General information
-
Organization nameQuidelOrtho Corporation (formerly Quidel Corporation)
-
Organization statusOperating organization
-
Address10165 McKellar Court San Diego, USA, 92121
-
Site
-
Previous organization nameQuidel (to 26/05/2022)
News
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameQuidelOrtho Corporation (formerly Quidel Corporation)
-
Organization statusOperating organization
-
Address10165 McKellar Court San Diego, USA, 92121
-
Site
-
Previous organization nameQuidel (to 26/05/2022)
Codes
-
LEI549300X2FQ6S98OQLQ46
-
SIC2835 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
-
NACE*** ***
-
NAICS*** ***
-
CIK0001906324
-
EIN87-4496285
